Edwards Lifesciences:

Date: Monday 9 October
Time: 12:45-14:00
Room: E1

THE NEW INSPIRIS RESILIA AORTIC VALVE: CURRENT EVIDENCE AND ITS EARLY CLINICAL APPLICATION

Chairs: O. Wendler, King’s College Hospital, London, UK – A. Diegeler, Herz- und Gefäßklinik in Bad Neustadt, Germany
WHAT’S NEW ABOUT THE NEW EUROPEAN AND AMERICAN GUIDELINES? Anno Diegeler, Herz- und Gefäßklinik in Bad Neustadt, Germany
EPIDEMIOLOGY AND CURRENT TREATMENT OPTIONS IN YOUNGER PATIENTS Ruggero De Paulis, European Hospital, Rome Italy
RESILIA TISSUE: 2-YEAR CLINICAL SAFETY TRIALS UPDATE David Heimonsohn, St. Vincent Heart Center of Indiana, US
REAL-LIFE CLINICAL DECISION MAKING with INSPIRIS RESILIA Olaf Wendler, King’s College Hospital, London, UK

 

 

Back to satellite list >>>